Susquehanna International Group’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-15,000
| Closed | -$227K | – | 14523 |
|
|
2022
Q3 | $227K | Buy |
+15,000
| New | +$174K | ﹤0.01% | 10518 |
|
|
2021
Q4 | – | Sell |
-11,100
| Closed | -$127K | – | 14289 |
|
|
2021
Q3 | $127K | Buy |
+11,100
| New | +$162K | ﹤0.01% | 11913 |
|
|
2020
Q4 | – | Sell |
-26,400
| Closed | -$311K | – | 11950 |
|
|
2020
Q3 | $311K | Buy |
26,400
+700
| +3% | +$8.53K | ﹤0.01% | 8628 |
|
|
2020
Q2 | $379K | Sell |
25,700
-92,500
| -78% | -$1.37M | ﹤0.01% | 7920 |
|
|
2020
Q1 | $1.6M | Buy |
118,200
+83,200
| +238% | +$1.58M | ﹤0.01% | 4385 |
|
|
2019
Q4 | $846K | Sell |
35,000
-26,200
| -43% | -$543K | ﹤0.01% | 5858 |
|
|
2019
Q3 | $1.18M | Buy |
61,200
+9,000
| +17% | +$206K | ﹤0.01% | 5337 |
|
|
2019
Q2 | $1.54M | Sell |
52,200
-7,200
| -12% | -$277K | ﹤0.01% | 4699 |
|
|
2019
Q1 | $2.82M | Sell |
59,400
-24,700
| -29% | -$1.09M | ﹤0.01% | 3220 |
|
|
2018
Q4 | $3.04M | Buy |
84,100
+400
| +0.5% | +$18.8K | ﹤0.01% | 2918 |
|
|
2018
Q3 | $5.15M | Sell |
83,700
-6,900
| -8% | -$444K | ﹤0.01% | 2665 |
|
|
2018
Q2 | $6.12M | Buy |
90,600
+27,400
| +43% | +$1.53M | ﹤0.01% | 2485 |
|
|
2018
Q1 | $3.43M | Sell |
63,200
-43,200
| -41% | -$2.42M | ﹤0.01% | 3049 |
|
|
2017
Q4 | $6.36M | Sell |
106,400
-124,400
| -54% | -$7.54M | ﹤0.01% | 2270 |
|
|
2017
Q3 | $11.2M | Buy |
230,800
+130,200
| +129% | +$7.1M | ﹤0.01% | 1664 |
|
|
2017
Q2 | $5.29M | Buy |
100,600
+14,700
| +17% | +$684K | ﹤0.01% | 2341 |
|
|
2017
Q1 | $3.9M | Buy |
85,900
+27,000
| +46% | +$1.2M | ﹤0.01% | 2639 |
|
|
2016
Q4 | $2.23M | Sell |
58,900
-146,700
| -71% | -$5.55M | ﹤0.01% | 3842 |
|
|
2016
Q3 | $7.76M | Buy |
205,600
+173,700
| +545% | +$3.83M | ﹤0.01% | 1751 |
|
|
2016
Q2 | $561K | Buy |
31,900
+19,200
| +151% | +$311K | ﹤0.01% | 5929 |
|
|
2016
Q1 | $154K | Sell |
12,700
-23,800
| -65% | -$377K | ﹤0.01% | 8191 |
|
|
2015
Q4 | $889K | Sell |
36,500
-67,300
| -65% | -$1.57M | ﹤0.01% | 5646 |
|
|
2015
Q3 | $1.84M | Sell |
103,800
-36,100
| -26% | -$654K | ﹤0.01% | 4446 |
|
|
2015
Q2 | $2.47M | Buy |
139,900
+113,900
| +438% | +$2.09M | ﹤0.01% | 4253 |
|
|
2015
Q1 | $815K | Buy |
+26,000
| New | +$754K | ﹤0.01% | 6164 |
|
Susquehanna International Group's AERI Position: Q4 2022 in Review
Susquehanna International Group sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 14,877 shares — an estimated $225K sold.
Susquehanna International Group first reported a position in AERI in Q1 2015 and held it in 22 quarters. The position peaked at $10.7M in Q4 2017. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Susquehanna International Group reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Susquehanna International Group sold 14,877 Aerie Pharmaceuticals shares in Q4 2022, an estimated $225K.
- Susquehanna International Group first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 22 quarters.
- Susquehanna International Group's Aerie Pharmaceuticals position peaked at $10.7M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.